192 related articles for article (PubMed ID: 24037780)
1. Emerging role of oxidative stress in metabolic syndrome and cardiovascular diseases: important role of Rac/NADPH oxidase.
Elnakish MT; Hassanain HH; Janssen PM; Angelos MG; Khan M
J Pathol; 2013 Nov; 231(3):290-300. PubMed ID: 24037780
[TBL] [Abstract][Full Text] [Related]
2. The NADPH oxidase family and its inhibitors.
Kleniewska P; Piechota A; Skibska B; Gorąca A
Arch Immunol Ther Exp (Warsz); 2012 Aug; 60(4):277-94. PubMed ID: 22696046
[TBL] [Abstract][Full Text] [Related]
3. Rac1 signalling mediates doxorubicin-induced cardiotoxicity through both reactive oxygen species-dependent and -independent pathways.
Ma J; Wang Y; Zheng D; Wei M; Xu H; Peng T
Cardiovasc Res; 2013 Jan; 97(1):77-87. PubMed ID: 23027656
[TBL] [Abstract][Full Text] [Related]
4. Assembly of the phagocyte NADPH oxidase complex: chimeric constructs derived from the cytosolic components as tools for exploring structure-function relationships.
Mizrahi A; Berdichevsky Y; Ugolev Y; Molshanski-Mor S; Nakash Y; Dahan I; Alloul N; Gorzalczany Y; Sarfstein R; Hirshberg M; Pick E
J Leukoc Biol; 2006 May; 79(5):881-95. PubMed ID: 16641134
[TBL] [Abstract][Full Text] [Related]
5. Endothelins and NADPH oxidases in the cardiovascular system.
Dammanahalli KJ; Sun Z
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):2-6. PubMed ID: 18047620
[TBL] [Abstract][Full Text] [Related]
6. Is mycophenolate more than just an immunosuppressant?--An overview.
Iyer A; Brown L
Indian J Biochem Biophys; 2009 Feb; 46(1):25-30. PubMed ID: 19374250
[TBL] [Abstract][Full Text] [Related]
7. Rac1 disrupts p67phox/p40phox binding: a novel role for Rac in NADPH oxidase activation.
Rinckel LA; Faris SL; Hitt ND; Kleinberg ME
Biochem Biophys Res Commun; 1999 Sep; 263(1):118-22. PubMed ID: 10486263
[TBL] [Abstract][Full Text] [Related]
8. A region N-terminal to the tandem SH3 domain of p47phox plays a crucial role in the activation of the phagocyte NADPH oxidase.
Taura M; Miyano K; Minakami R; Kamakura S; Takeya R; Sumimoto H
Biochem J; 2009 Apr; 419(2):329-38. PubMed ID: 19090790
[TBL] [Abstract][Full Text] [Related]
9. Rac-1 as a new therapeutic target in cerebro- and cardio-vascular diseases.
Carrizzo A; Forte M; Lembo M; Formisano L; Puca AA; Vecchione C
Curr Drug Targets; 2014; 15(13):1231-46. PubMed ID: 25345393
[TBL] [Abstract][Full Text] [Related]
10. Vascular NADPH oxidases as drug targets for novel antioxidant strategies.
Guzik TJ; Harrison DG
Drug Discov Today; 2006 Jun; 11(11-12):524-33. PubMed ID: 16713904
[TBL] [Abstract][Full Text] [Related]
11. Regulation of NADPH oxidases: the role of Rac proteins.
Hordijk PL
Circ Res; 2006 Mar; 98(4):453-62. PubMed ID: 16514078
[TBL] [Abstract][Full Text] [Related]
12. NOX family NADPH oxidases in liver and in pancreatic islets: a role in the metabolic syndrome and diabetes?
Guichard C; Moreau R; Pessayre D; Epperson TK; Krause KH
Biochem Soc Trans; 2008 Oct; 36(Pt 5):920-9. PubMed ID: 18793162
[TBL] [Abstract][Full Text] [Related]
13. Albumin activation of NAD(P)H oxidase activity is mediated via Rac1 in proximal tubule cells.
Whaley-Connell AT; Morris EM; Rehmer N; Yaghoubian JC; Wei Y; Hayden MR; Habibi J; Stump CS; Sowers JR
Am J Nephrol; 2007; 27(1):15-23. PubMed ID: 17204833
[TBL] [Abstract][Full Text] [Related]
14. Novel therapeutic approaches in limiting oxidative stress and inflammation.
Spychalowicz A; Wilk G; Śliwa T; Ludew D; Guzik TJ
Curr Pharm Biotechnol; 2012 Oct; 13(13):2456-66. PubMed ID: 22280420
[TBL] [Abstract][Full Text] [Related]
15. NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities.
Paravicini TM; Touyz RM
Diabetes Care; 2008 Feb; 31 Suppl 2():S170-80. PubMed ID: 18227481
[TBL] [Abstract][Full Text] [Related]
16. The role of oxidative stress and NADPH oxidase in the pathogenesis of atherosclerosis.
Bryk D; Olejarz W; Zapolska-Downar D
Postepy Hig Med Dosw (Online); 2017 Jan; 71(0):57-68. PubMed ID: 28181912
[TBL] [Abstract][Full Text] [Related]
17. TNF-alpha/cycloheximide-induced apoptosis in intestinal epithelial cells requires Rac1-regulated reactive oxygen species.
Jin S; Ray RM; Johnson LR
Am J Physiol Gastrointest Liver Physiol; 2008 Apr; 294(4):G928-37. PubMed ID: 18218673
[TBL] [Abstract][Full Text] [Related]
18. Rosiglitazone reduces glucose-induced oxidative stress mediated by NAD(P)H oxidase via AMPK-dependent mechanism.
Ceolotto G; Gallo A; Papparella I; Franco L; Murphy E; Iori E; Pagnin E; Fadini GP; Albiero M; Semplicini A; Avogaro A
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2627-33. PubMed ID: 17916771
[TBL] [Abstract][Full Text] [Related]
19. [The Nox/Duox family of ROS-generating NADPH oxidases].
Guichard C; Pedruzzi E; Fay M; Ben Mkaddem S; Coant N; Daniel F; Ogier-Denis E
Med Sci (Paris); 2006 Nov; 22(11):953-9. PubMed ID: 17101097
[TBL] [Abstract][Full Text] [Related]
20. Oxidative stress and diabetic cardiovascular disorders: roles of mitochondria and NADPH oxidase.
Shen GX
Can J Physiol Pharmacol; 2010 Mar; 88(3):241-8. PubMed ID: 20393589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
